We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.68B
AUM Growth
-$270M
(-5.5%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
11.36%
Holding
1,103
New
193
Increased
369
Reduced
317
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$25.2M |
| 2 |
Ashland
ASH
|
+$17.2M |
| 3 |
IBM
IBM
|
+$17.1M |
| 4 |
Madison Square Garden
MSGS
|
+$16.7M |
| 5 |
Valero Energy
VLO
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$35.9M |
| 2 |
Qualcomm
QCOM
|
+$29M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$27.5M |
| 4 |
Agilent Technologies
A
|
+$26.4M |
| 5 |
Northrop Grumman
NOC
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 19.14% |
| 3 | Healthcare | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBC
326
DELISTED
WABCO HOLDINGS INC.
WBC
| $3.2M | 0.07% |
+25,090
| New | +$3M |
|
327
Equinix
EQIX
$109B
| $3.19M | 0.07% |
7,442
+2,560
| +52% | +$1.09M |
|
328
Lincoln National
LNC
$7.83B
| $3.18M | 0.07% |
47,060
-22,250
| -32% | -$1.47M |
|
|
BV
329
DELISTED
Bazaarvoice, Inc.
BV
| $3.18M | 0.07% |
641,756
+67,800
| +12% | +$313K |
|
|
FOE
330
DELISTED
Ferro Corporation
FOE
| $3.15M | 0.07% |
172,230
+73,000
| +74% | +$1.25M |
|
331
Evercore
EVR
$13.2B
| $3.13M | 0.07% |
44,330
-66,160
| -60% | -$4.81M |
|
332
O-I Glass
OI
$1.38B
| $3.12M | 0.07% |
130,560
-333,037
| -72% | -$7.32M |
|
333
Ulta Beauty
ULTA
$20.5B
| $3.11M | 0.07% |
10,816
+9,612
| +798% | +$2.81M |
|
334
Archrock
AROC
$6.51B
| $3.09M | 0.07% |
271,320
-55,880
| -17% | -$640K |
|
335
Autoliv
ALV
$8.61B
| $3.06M | 0.07% |
38,711
+25,955
| +203% | +$1.97M |
|
|
LPT
336
DELISTED
Liberty Property Trust
LPT
| $3.06M | 0.07% |
75,060
+5,960
| +9% | +$245K |
|
337
Stepan Co
SCL
$1.32B
| $3.01M | 0.06% |
34,507
-4,290
| -11% | -$361K |
|
338
Cullen/Frost Bankers
CFR
$10.3B
| $3M | 0.06% |
31,970
+870
| +3% | +$80.3K |
|
339
Quad
QUAD
$429M
| $3M | 0.06% |
130,948
-6,100
| -4% | -$145K |
|
340
RLJ Lodging Trust
RLJ
$1.88B
| $3M | 0.06% |
+150,900
| New | +$3.23M |
|
|
IPCC
341
DELISTED
Infinity Property & Casualty C
IPCC
| $2.99M | 0.06% |
31,799
+25,670
| +419% | +$2.45M |
|
342
Seagate
STX
$201B
| $2.96M | 0.06% |
76,500
-18,080
| -19% | -$789K |
|
343
Exelon
EXC
$48.5B
| $2.96M | 0.06% |
115,020
-273,783
| -70% | -$6.97M |
|
344
Advanced Micro Devices
AMD
$877B
| $2.95M | 0.06% |
236,200
| – | – |
|
345
Xcel Energy
XEL
$50.9B
| $2.93M | 0.06% |
63,790
| – | – |
|
|
VCRA
346
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $2.92M | 0.06% |
110,316
-19,444
| -15% | -$498K |
|
347
LiveRamp
RAMP
$2.29B
| $2.9M | 0.06% |
111,767
+90,317
| +421% | +$2.46M |
|
348
Enova International
ENVA
$5.87B
| $2.9M | 0.06% |
195,283
+77,120
| +65% | +$1.09M |
|
349
Upbound Group
UPBD
$1.24B
| $2.9M | 0.06% |
247,400
-40,100
| -14% | -$453K |
|
350
First Bancorp
FBP
$4.4B
| $2.88M | 0.06% |
497,810
+160,800
| +48% | +$902K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2017 Portfolio in Review
As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.
- Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
- Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
- Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
- Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
- Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
- Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.